Global Drug, Anti-infective Market Report 2019, Competitive Landscape, Trends and Opportunities
The Drug, Anti-infective market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Drug, Anti-infective market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Drug, Anti-infective market.
Major players in the global Drug, Anti-infective market include:
Theravance
GlaxoSmithKline
Gilead Sciences
Pfizer
Johnson
Optimer Pharmaceuticals
MerLion Pharma
Daiichi Sankyo
Abbott
Sanofi-Aventis
Nanosphere
Bristol-Myers Squibb
Wyeth
Basilea Pharmaceutica AG
Obetech
Roche Pharma AG
Novartis AG
Novabay Pharmaceuticals
Merck
NanoViricides
On the basis of types, the Drug, Anti-infective market is primarily split into:
OTC
Rx Drugs
On the basis of applications, the market covers:
Hospital
Drugs Store
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Drug, Anti-infective market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Drug, Anti-infective market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Drug, Anti-infective industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Drug, Anti-infective market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Drug, Anti-infective, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Drug, Anti-infective in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Drug, Anti-infective in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Drug, Anti-infective. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Drug, Anti-infective market, including the global production and revenue forecast, regional forecast. It also foresees the Drug, Anti-infective market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
The report mainly studies the size, recent trends and development status of the Drug, Anti-infective market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Drug, Anti-infective market.
Major players in the global Drug, Anti-infective market include:
Theravance
GlaxoSmithKline
Gilead Sciences
Pfizer
Johnson
Optimer Pharmaceuticals
MerLion Pharma
Daiichi Sankyo
Abbott
Sanofi-Aventis
Nanosphere
Bristol-Myers Squibb
Wyeth
Basilea Pharmaceutica AG
Obetech
Roche Pharma AG
Novartis AG
Novabay Pharmaceuticals
Merck
NanoViricides
On the basis of types, the Drug, Anti-infective market is primarily split into:
OTC
Rx Drugs
On the basis of applications, the market covers:
Hospital
Drugs Store
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Drug, Anti-infective market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Drug, Anti-infective market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Drug, Anti-infective industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Drug, Anti-infective market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Drug, Anti-infective, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Drug, Anti-infective in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Drug, Anti-infective in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Drug, Anti-infective. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Drug, Anti-infective market, including the global production and revenue forecast, regional forecast. It also foresees the Drug, Anti-infective market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
- Historical Years: 2014-2018
- Base Year: 2019
- Estimated Year: 2019
- Forecast Period: 2019-2026
1 DRUG, ANTI-INFECTIVE MARKET OVERVIEW
1.1 Product Overview and Scope of Drug, Anti-infective
1.2 Drug, Anti-infective Segment by Type
1.2.1 Global Drug, Anti-infective Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of OTC
1.2.3 The Market Profile of Rx Drugs
1.3 Global Drug, Anti-infective Segment by Application
1.3.1 Drug, Anti-infective Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Hospital
1.3.3 The Market Profile of Drugs Store
1.3.4 The Market Profile of Others
1.4 Global Drug, Anti-infective Market by Region (2014-2026)
1.4.1 Global Drug, Anti-infective Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3 Europe Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.1 Germany Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.2 UK Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.3 France Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.4 Italy Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.5 Spain Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.6 Russia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.7 Poland Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.4 China Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.5 Japan Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.6 India Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.8 Central and South America Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Drug, Anti-infective Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Drug, Anti-infective (2014-2026)
1.5.1 Global Drug, Anti-infective Revenue Status and Outlook (2014-2026)
1.5.2 Global Drug, Anti-infective Production Status and Outlook (2014-2026)
2 GLOBAL DRUG, ANTI-INFECTIVE MARKET LANDSCAPE BY PLAYER
2.1 Global Drug, Anti-infective Production and Share by Player (2014-2019)
2.2 Global Drug, Anti-infective Revenue and Market Share by Player (2014-2019)
2.3 Global Drug, Anti-infective Average Price by Player (2014-2019)
2.4 Drug, Anti-infective Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Drug, Anti-infective Market Competitive Situation and Trends
2.5.1 Drug, Anti-infective Market Concentration Rate
2.5.2 Drug, Anti-infective Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Theravance
3.1.1 Theravance Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Drug, Anti-infective Product Profiles, Application and Specification
3.1.3 Theravance Drug, Anti-infective Market Performance (2014-2019)
3.1.4 Theravance Business Overview
3.2 GlaxoSmithKline
3.2.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Drug, Anti-infective Product Profiles, Application and Specification
3.2.3 GlaxoSmithKline Drug, Anti-infective Market Performance (2014-2019)
3.2.4 GlaxoSmithKline Business Overview
3.3 Gilead Sciences
3.3.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Drug, Anti-infective Product Profiles, Application and Specification
3.3.3 Gilead Sciences Drug, Anti-infective Market Performance (2014-2019)
3.3.4 Gilead Sciences Business Overview
3.4 Pfizer
3.4.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Drug, Anti-infective Product Profiles, Application and Specification
3.4.3 Pfizer Drug, Anti-infective Market Performance (2014-2019)
3.4.4 Pfizer Business Overview
3.5 Johnson
3.5.1 Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Drug, Anti-infective Product Profiles, Application and Specification
3.5.3 Johnson Drug, Anti-infective Market Performance (2014-2019)
3.5.4 Johnson Business Overview
3.6 Optimer Pharmaceuticals
3.6.1 Optimer Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Drug, Anti-infective Product Profiles, Application and Specification
3.6.3 Optimer Pharmaceuticals Drug, Anti-infective Market Performance (2014-2019)
3.6.4 Optimer Pharmaceuticals Business Overview
3.7 MerLion Pharma
3.7.1 MerLion Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Drug, Anti-infective Product Profiles, Application and Specification
3.7.3 MerLion Pharma Drug, Anti-infective Market Performance (2014-2019)
3.7.4 MerLion Pharma Business Overview
3.8 Daiichi Sankyo
3.8.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Drug, Anti-infective Product Profiles, Application and Specification
3.8.3 Daiichi Sankyo Drug, Anti-infective Market Performance (2014-2019)
3.8.4 Daiichi Sankyo Business Overview
3.9 Abbott
3.9.1 Abbott Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Drug, Anti-infective Product Profiles, Application and Specification
3.9.3 Abbott Drug, Anti-infective Market Performance (2014-2019)
3.9.4 Abbott Business Overview
3.10 Sanofi-Aventis
3.10.1 Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Drug, Anti-infective Product Profiles, Application and Specification
3.10.3 Sanofi-Aventis Drug, Anti-infective Market Performance (2014-2019)
3.10.4 Sanofi-Aventis Business Overview
3.11 Nanosphere
3.11.1 Nanosphere Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Drug, Anti-infective Product Profiles, Application and Specification
3.11.3 Nanosphere Drug, Anti-infective Market Performance (2014-2019)
3.11.4 Nanosphere Business Overview
3.12 Bristol-Myers Squibb
3.12.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Drug, Anti-infective Product Profiles, Application and Specification
3.12.3 Bristol-Myers Squibb Drug, Anti-infective Market Performance (2014-2019)
3.12.4 Bristol-Myers Squibb Business Overview
3.13 Wyeth
3.13.1 Wyeth Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Drug, Anti-infective Product Profiles, Application and Specification
3.13.3 Wyeth Drug, Anti-infective Market Performance (2014-2019)
3.13.4 Wyeth Business Overview
3.14 Basilea Pharmaceutica AG
3.14.1 Basilea Pharmaceutica AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Drug, Anti-infective Product Profiles, Application and Specification
3.14.3 Basilea Pharmaceutica AG Drug, Anti-infective Market Performance (2014-2019)
3.14.4 Basilea Pharmaceutica AG Business Overview
3.15 Obetech
3.15.1 Obetech Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Drug, Anti-infective Product Profiles, Application and Specification
3.15.3 Obetech Drug, Anti-infective Market Performance (2014-2019)
3.15.4 Obetech Business Overview
3.16 Roche Pharma AG
3.16.1 Roche Pharma AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Drug, Anti-infective Product Profiles, Application and Specification
3.16.3 Roche Pharma AG Drug, Anti-infective Market Performance (2014-2019)
3.16.4 Roche Pharma AG Business Overview
3.17 Novartis AG
3.17.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Drug, Anti-infective Product Profiles, Application and Specification
3.17.3 Novartis AG Drug, Anti-infective Market Performance (2014-2019)
3.17.4 Novartis AG Business Overview
3.18 Novabay Pharmaceuticals
3.18.1 Novabay Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Drug, Anti-infective Product Profiles, Application and Specification
3.18.3 Novabay Pharmaceuticals Drug, Anti-infective Market Performance (2014-2019)
3.18.4 Novabay Pharmaceuticals Business Overview
3.19 Merck
3.19.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Drug, Anti-infective Product Profiles, Application and Specification
3.19.3 Merck Drug, Anti-infective Market Performance (2014-2019)
3.19.4 Merck Business Overview
3.20 NanoViricides
3.20.1 NanoViricides Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Drug, Anti-infective Product Profiles, Application and Specification
3.20.3 NanoViricides Drug, Anti-infective Market Performance (2014-2019)
3.20.4 NanoViricides Business Overview
4 GLOBAL DRUG, ANTI-INFECTIVE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Drug, Anti-infective Production and Market Share by Type (2014-2019)
4.2 Global Drug, Anti-infective Revenue and Market Share by Type (2014-2019)
4.3 Global Drug, Anti-infective Price by Type (2014-2019)
4.4 Global Drug, Anti-infective Production Growth Rate by Type (2014-2019)
4.4.1 Global Drug, Anti-infective Production Growth Rate of OTC (2014-2019)
4.4.2 Global Drug, Anti-infective Production Growth Rate of Rx Drugs (2014-2019)
5 GLOBAL DRUG, ANTI-INFECTIVE MARKET ANALYSIS BY APPLICATION
5.1 Global Drug, Anti-infective Consumption and Market Share by Application (2014-2019)
5.2 Global Drug, Anti-infective Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Drug, Anti-infective Consumption Growth Rate of Hospital (2014-2019)
5.2.2 Global Drug, Anti-infective Consumption Growth Rate of Drugs Store (2014-2019)
5.2.3 Global Drug, Anti-infective Consumption Growth Rate of Others (2014-2019)
6 GLOBAL DRUG, ANTI-INFECTIVE PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Drug, Anti-infective Consumption by Region (2014-2019)
6.2 United States Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.3 Europe Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.4 China Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.5 Japan Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.6 India Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
7 GLOBAL DRUG, ANTI-INFECTIVE PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Drug, Anti-infective Production and Market Share by Region (2014-2019)
7.2 Global Drug, Anti-infective Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
8 DRUG, ANTI-INFECTIVE MANUFACTURING ANALYSIS
8.1 Drug, Anti-infective Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Drug, Anti-infective
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Drug, Anti-infective Industrial Chain Analysis
9.2 Raw Materials Sources of Drug, Anti-infective Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Drug, Anti-infective
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL DRUG, ANTI-INFECTIVE MARKET FORECAST (2019-2026)
11.1 Global Drug, Anti-infective Production, Revenue Forecast (2019-2026)
11.1.1 Global Drug, Anti-infective Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Drug, Anti-infective Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Drug, Anti-infective Price and Trend Forecast (2019-2026)
11.2 Global Drug, Anti-infective Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Drug, Anti-infective Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Drug, Anti-infective Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Drug, Anti-infective
1.2 Drug, Anti-infective Segment by Type
1.2.1 Global Drug, Anti-infective Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of OTC
1.2.3 The Market Profile of Rx Drugs
1.3 Global Drug, Anti-infective Segment by Application
1.3.1 Drug, Anti-infective Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Hospital
1.3.3 The Market Profile of Drugs Store
1.3.4 The Market Profile of Others
1.4 Global Drug, Anti-infective Market by Region (2014-2026)
1.4.1 Global Drug, Anti-infective Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3 Europe Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.1 Germany Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.2 UK Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.3 France Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.4 Italy Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.5 Spain Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.6 Russia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.3.7 Poland Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.4 China Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.5 Japan Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.6 India Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.8 Central and South America Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Drug, Anti-infective Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Drug, Anti-infective Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Drug, Anti-infective (2014-2026)
1.5.1 Global Drug, Anti-infective Revenue Status and Outlook (2014-2026)
1.5.2 Global Drug, Anti-infective Production Status and Outlook (2014-2026)
2 GLOBAL DRUG, ANTI-INFECTIVE MARKET LANDSCAPE BY PLAYER
2.1 Global Drug, Anti-infective Production and Share by Player (2014-2019)
2.2 Global Drug, Anti-infective Revenue and Market Share by Player (2014-2019)
2.3 Global Drug, Anti-infective Average Price by Player (2014-2019)
2.4 Drug, Anti-infective Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Drug, Anti-infective Market Competitive Situation and Trends
2.5.1 Drug, Anti-infective Market Concentration Rate
2.5.2 Drug, Anti-infective Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Theravance
3.1.1 Theravance Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Drug, Anti-infective Product Profiles, Application and Specification
3.1.3 Theravance Drug, Anti-infective Market Performance (2014-2019)
3.1.4 Theravance Business Overview
3.2 GlaxoSmithKline
3.2.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Drug, Anti-infective Product Profiles, Application and Specification
3.2.3 GlaxoSmithKline Drug, Anti-infective Market Performance (2014-2019)
3.2.4 GlaxoSmithKline Business Overview
3.3 Gilead Sciences
3.3.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Drug, Anti-infective Product Profiles, Application and Specification
3.3.3 Gilead Sciences Drug, Anti-infective Market Performance (2014-2019)
3.3.4 Gilead Sciences Business Overview
3.4 Pfizer
3.4.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Drug, Anti-infective Product Profiles, Application and Specification
3.4.3 Pfizer Drug, Anti-infective Market Performance (2014-2019)
3.4.4 Pfizer Business Overview
3.5 Johnson
3.5.1 Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Drug, Anti-infective Product Profiles, Application and Specification
3.5.3 Johnson Drug, Anti-infective Market Performance (2014-2019)
3.5.4 Johnson Business Overview
3.6 Optimer Pharmaceuticals
3.6.1 Optimer Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Drug, Anti-infective Product Profiles, Application and Specification
3.6.3 Optimer Pharmaceuticals Drug, Anti-infective Market Performance (2014-2019)
3.6.4 Optimer Pharmaceuticals Business Overview
3.7 MerLion Pharma
3.7.1 MerLion Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Drug, Anti-infective Product Profiles, Application and Specification
3.7.3 MerLion Pharma Drug, Anti-infective Market Performance (2014-2019)
3.7.4 MerLion Pharma Business Overview
3.8 Daiichi Sankyo
3.8.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Drug, Anti-infective Product Profiles, Application and Specification
3.8.3 Daiichi Sankyo Drug, Anti-infective Market Performance (2014-2019)
3.8.4 Daiichi Sankyo Business Overview
3.9 Abbott
3.9.1 Abbott Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Drug, Anti-infective Product Profiles, Application and Specification
3.9.3 Abbott Drug, Anti-infective Market Performance (2014-2019)
3.9.4 Abbott Business Overview
3.10 Sanofi-Aventis
3.10.1 Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Drug, Anti-infective Product Profiles, Application and Specification
3.10.3 Sanofi-Aventis Drug, Anti-infective Market Performance (2014-2019)
3.10.4 Sanofi-Aventis Business Overview
3.11 Nanosphere
3.11.1 Nanosphere Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Drug, Anti-infective Product Profiles, Application and Specification
3.11.3 Nanosphere Drug, Anti-infective Market Performance (2014-2019)
3.11.4 Nanosphere Business Overview
3.12 Bristol-Myers Squibb
3.12.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Drug, Anti-infective Product Profiles, Application and Specification
3.12.3 Bristol-Myers Squibb Drug, Anti-infective Market Performance (2014-2019)
3.12.4 Bristol-Myers Squibb Business Overview
3.13 Wyeth
3.13.1 Wyeth Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Drug, Anti-infective Product Profiles, Application and Specification
3.13.3 Wyeth Drug, Anti-infective Market Performance (2014-2019)
3.13.4 Wyeth Business Overview
3.14 Basilea Pharmaceutica AG
3.14.1 Basilea Pharmaceutica AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Drug, Anti-infective Product Profiles, Application and Specification
3.14.3 Basilea Pharmaceutica AG Drug, Anti-infective Market Performance (2014-2019)
3.14.4 Basilea Pharmaceutica AG Business Overview
3.15 Obetech
3.15.1 Obetech Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Drug, Anti-infective Product Profiles, Application and Specification
3.15.3 Obetech Drug, Anti-infective Market Performance (2014-2019)
3.15.4 Obetech Business Overview
3.16 Roche Pharma AG
3.16.1 Roche Pharma AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Drug, Anti-infective Product Profiles, Application and Specification
3.16.3 Roche Pharma AG Drug, Anti-infective Market Performance (2014-2019)
3.16.4 Roche Pharma AG Business Overview
3.17 Novartis AG
3.17.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Drug, Anti-infective Product Profiles, Application and Specification
3.17.3 Novartis AG Drug, Anti-infective Market Performance (2014-2019)
3.17.4 Novartis AG Business Overview
3.18 Novabay Pharmaceuticals
3.18.1 Novabay Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Drug, Anti-infective Product Profiles, Application and Specification
3.18.3 Novabay Pharmaceuticals Drug, Anti-infective Market Performance (2014-2019)
3.18.4 Novabay Pharmaceuticals Business Overview
3.19 Merck
3.19.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Drug, Anti-infective Product Profiles, Application and Specification
3.19.3 Merck Drug, Anti-infective Market Performance (2014-2019)
3.19.4 Merck Business Overview
3.20 NanoViricides
3.20.1 NanoViricides Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Drug, Anti-infective Product Profiles, Application and Specification
3.20.3 NanoViricides Drug, Anti-infective Market Performance (2014-2019)
3.20.4 NanoViricides Business Overview
4 GLOBAL DRUG, ANTI-INFECTIVE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Drug, Anti-infective Production and Market Share by Type (2014-2019)
4.2 Global Drug, Anti-infective Revenue and Market Share by Type (2014-2019)
4.3 Global Drug, Anti-infective Price by Type (2014-2019)
4.4 Global Drug, Anti-infective Production Growth Rate by Type (2014-2019)
4.4.1 Global Drug, Anti-infective Production Growth Rate of OTC (2014-2019)
4.4.2 Global Drug, Anti-infective Production Growth Rate of Rx Drugs (2014-2019)
5 GLOBAL DRUG, ANTI-INFECTIVE MARKET ANALYSIS BY APPLICATION
5.1 Global Drug, Anti-infective Consumption and Market Share by Application (2014-2019)
5.2 Global Drug, Anti-infective Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Drug, Anti-infective Consumption Growth Rate of Hospital (2014-2019)
5.2.2 Global Drug, Anti-infective Consumption Growth Rate of Drugs Store (2014-2019)
5.2.3 Global Drug, Anti-infective Consumption Growth Rate of Others (2014-2019)
6 GLOBAL DRUG, ANTI-INFECTIVE PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Drug, Anti-infective Consumption by Region (2014-2019)
6.2 United States Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.3 Europe Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.4 China Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.5 Japan Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.6 India Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
7 GLOBAL DRUG, ANTI-INFECTIVE PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Drug, Anti-infective Production and Market Share by Region (2014-2019)
7.2 Global Drug, Anti-infective Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
8 DRUG, ANTI-INFECTIVE MANUFACTURING ANALYSIS
8.1 Drug, Anti-infective Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Drug, Anti-infective
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Drug, Anti-infective Industrial Chain Analysis
9.2 Raw Materials Sources of Drug, Anti-infective Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Drug, Anti-infective
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL DRUG, ANTI-INFECTIVE MARKET FORECAST (2019-2026)
11.1 Global Drug, Anti-infective Production, Revenue Forecast (2019-2026)
11.1.1 Global Drug, Anti-infective Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Drug, Anti-infective Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Drug, Anti-infective Price and Trend Forecast (2019-2026)
11.2 Global Drug, Anti-infective Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Drug, Anti-infective Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Drug, Anti-infective Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Drug, Anti-infective Product Picture
Table Global Drug, Anti-infective Production and CAGR (%) Comparison by Type
Table Profile of OTC
Table Profile of Rx Drugs
Table Drug, Anti-infective Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Hospital
Table Profile of Drugs Store
Table Profile of Others
Figure Global Drug, Anti-infective Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Europe Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Germany Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure UK Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure France Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Italy Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Spain Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Russia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Poland Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure China Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Japan Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure India Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Malaysia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Singapore Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Philippines Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Indonesia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Thailand Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Vietnam Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Central and South America Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Brazil Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Mexico Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Colombia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Turkey Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Egypt Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure South Africa Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Nigeria Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Global Drug, Anti-infective Production Status and Outlook (2014-2026)
Table Global Drug, Anti-infective Production by Player (2014-2019)
Table Global Drug, Anti-infective Production Share by Player (2014-2019)
Figure Global Drug, Anti-infective Production Share by Player in 2018
Table Drug, Anti-infective Revenue by Player (2014-2019)
Table Drug, Anti-infective Revenue Market Share by Player (2014-2019)
Table Drug, Anti-infective Price by Player (2014-2019)
Table Drug, Anti-infective Manufacturing Base Distribution and Sales Area by Player
Table Drug, Anti-infective Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table Theravance Profile
Table Theravance Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Gilead Sciences Profile
Table Gilead Sciences Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Profile
Table Pfizer Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Johnson Profile
Table Johnson Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Optimer Pharmaceuticals Profile
Table Optimer Pharmaceuticals Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table MerLion Pharma Profile
Table MerLion Pharma Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Abbott Profile
Table Abbott Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Sanofi-Aventis Profile
Table Sanofi-Aventis Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Nanosphere Profile
Table Nanosphere Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Wyeth Profile
Table Wyeth Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Basilea Pharmaceutica AG Profile
Table Basilea Pharmaceutica AG Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Obetech Profile
Table Obetech Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Roche Pharma AG Profile
Table Roche Pharma AG Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis AG Profile
Table Novartis AG Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Novabay Pharmaceuticals Profile
Table Novabay Pharmaceuticals Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck Profile
Table Merck Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table NanoViricides Profile
Table NanoViricides Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Drug, Anti-infective Production by Type (2014-2019)
Table Global Drug, Anti-infective Production Market Share by Type (2014-2019)
Figure Global Drug, Anti-infective Production Market Share by Type in 2018
Table Global Drug, Anti-infective Revenue by Type (2014-2019)
Table Global Drug, Anti-infective Revenue Market Share by Type (2014-2019)
Figure Global Drug, Anti-infective Revenue Market Share by Type in 2018
Table Drug, Anti-infective Price by Type (2014-2019)
Figure Global Drug, Anti-infective Production Growth Rate of OTC (2014-2019)
Figure Global Drug, Anti-infective Production Growth Rate of Rx Drugs (2014-2019)
Table Global Drug, Anti-infective Consumption by Application (2014-2019)
Table Global Drug, Anti-infective Consumption Market Share by Application (2014-2019)
Table Global Drug, Anti-infective Consumption of Hospital (2014-2019)
Table Global Drug, Anti-infective Consumption of Drugs Store (2014-2019)
Table Global Drug, Anti-infective Consumption of Others (2014-2019)
Table Global Drug, Anti-infective Consumption by Region (2014-2019)
Table Global Drug, Anti-infective Consumption Market Share by Region (2014-2019)
Table United States Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Europe Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table China Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Japan Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table India Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Central and South America Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Global Drug, Anti-infective Production by Region (2014-2019)
Table Global Drug, Anti-infective Production Market Share by Region (2014-2019)
Figure Global Drug, Anti-infective Production Market Share by Region (2014-2019)
Figure Global Drug, Anti-infective Production Market Share by Region in 2018
Table Global Drug, Anti-infective Revenue by Region (2014-2019)
Table Global Drug, Anti-infective Revenue Market Share by Region (2014-2019)
Figure Global Drug, Anti-infective Revenue Market Share by Region (2014-2019)
Figure Global Drug, Anti-infective Revenue Market Share by Region in 2018
Table Global Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table China Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table India Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Drug, Anti-infective
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Drug, Anti-infective
Figure Drug, Anti-infective Industrial Chain Analysis
Table Raw Materials Sources of Drug, Anti-infective Major Players in 2018
Table Downstream Buyers
Figure Global Drug, Anti-infective Production and Growth Rate Forecast (2019-2026)
Figure Global Drug, Anti-infective Revenue and Growth Rate Forecast (2019-2026)
Figure Global Drug, Anti-infective Price and Trend Forecast (2019-2026)
Table United States Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table China Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Japan Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table India Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Middle East and Africa Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Global Drug, Anti-infective Market Production Forecast, by Type
Table Global Drug, Anti-infective Production Volume Market Share Forecast, by Type
Table Global Drug, Anti-infective Market Revenue Forecast, by Type
Table Global Drug, Anti-infective Revenue Market Share Forecast, by Type
Table Global Drug, Anti-infective Price Forecast, by Type
Table Global Drug, Anti-infective Market Production Forecast, by Application
Table Global Drug, Anti-infective Production Volume Market Share Forecast, by Application
Table Global Drug, Anti-infective Market Revenue Forecast, by Application
Table Global Drug, Anti-infective Revenue Market Share Forecast, by Application
Table Global Drug, Anti-infective Price Forecast, by Application
Figure Drug, Anti-infective Product Picture
Table Global Drug, Anti-infective Production and CAGR (%) Comparison by Type
Table Profile of OTC
Table Profile of Rx Drugs
Table Drug, Anti-infective Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Hospital
Table Profile of Drugs Store
Table Profile of Others
Figure Global Drug, Anti-infective Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Europe Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Germany Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure UK Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure France Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Italy Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Spain Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Russia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Poland Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure China Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Japan Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure India Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Malaysia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Singapore Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Philippines Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Indonesia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Thailand Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Vietnam Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Central and South America Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Brazil Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Mexico Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Colombia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Turkey Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Egypt Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure South Africa Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Nigeria Drug, Anti-infective Revenue and Growth Rate (2014-2026)
Figure Global Drug, Anti-infective Production Status and Outlook (2014-2026)
Table Global Drug, Anti-infective Production by Player (2014-2019)
Table Global Drug, Anti-infective Production Share by Player (2014-2019)
Figure Global Drug, Anti-infective Production Share by Player in 2018
Table Drug, Anti-infective Revenue by Player (2014-2019)
Table Drug, Anti-infective Revenue Market Share by Player (2014-2019)
Table Drug, Anti-infective Price by Player (2014-2019)
Table Drug, Anti-infective Manufacturing Base Distribution and Sales Area by Player
Table Drug, Anti-infective Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table Theravance Profile
Table Theravance Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Gilead Sciences Profile
Table Gilead Sciences Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Profile
Table Pfizer Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Johnson Profile
Table Johnson Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Optimer Pharmaceuticals Profile
Table Optimer Pharmaceuticals Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table MerLion Pharma Profile
Table MerLion Pharma Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Abbott Profile
Table Abbott Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Sanofi-Aventis Profile
Table Sanofi-Aventis Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Nanosphere Profile
Table Nanosphere Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Wyeth Profile
Table Wyeth Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Basilea Pharmaceutica AG Profile
Table Basilea Pharmaceutica AG Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Obetech Profile
Table Obetech Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Roche Pharma AG Profile
Table Roche Pharma AG Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis AG Profile
Table Novartis AG Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Novabay Pharmaceuticals Profile
Table Novabay Pharmaceuticals Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck Profile
Table Merck Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table NanoViricides Profile
Table NanoViricides Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Drug, Anti-infective Production by Type (2014-2019)
Table Global Drug, Anti-infective Production Market Share by Type (2014-2019)
Figure Global Drug, Anti-infective Production Market Share by Type in 2018
Table Global Drug, Anti-infective Revenue by Type (2014-2019)
Table Global Drug, Anti-infective Revenue Market Share by Type (2014-2019)
Figure Global Drug, Anti-infective Revenue Market Share by Type in 2018
Table Drug, Anti-infective Price by Type (2014-2019)
Figure Global Drug, Anti-infective Production Growth Rate of OTC (2014-2019)
Figure Global Drug, Anti-infective Production Growth Rate of Rx Drugs (2014-2019)
Table Global Drug, Anti-infective Consumption by Application (2014-2019)
Table Global Drug, Anti-infective Consumption Market Share by Application (2014-2019)
Table Global Drug, Anti-infective Consumption of Hospital (2014-2019)
Table Global Drug, Anti-infective Consumption of Drugs Store (2014-2019)
Table Global Drug, Anti-infective Consumption of Others (2014-2019)
Table Global Drug, Anti-infective Consumption by Region (2014-2019)
Table Global Drug, Anti-infective Consumption Market Share by Region (2014-2019)
Table United States Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Europe Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table China Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Japan Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table India Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Central and South America Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Drug, Anti-infective Production, Consumption, Export, Import (2014-2019)
Table Global Drug, Anti-infective Production by Region (2014-2019)
Table Global Drug, Anti-infective Production Market Share by Region (2014-2019)
Figure Global Drug, Anti-infective Production Market Share by Region (2014-2019)
Figure Global Drug, Anti-infective Production Market Share by Region in 2018
Table Global Drug, Anti-infective Revenue by Region (2014-2019)
Table Global Drug, Anti-infective Revenue Market Share by Region (2014-2019)
Figure Global Drug, Anti-infective Revenue Market Share by Region (2014-2019)
Figure Global Drug, Anti-infective Revenue Market Share by Region in 2018
Table Global Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table China Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table India Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Drug, Anti-infective Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Drug, Anti-infective
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Drug, Anti-infective
Figure Drug, Anti-infective Industrial Chain Analysis
Table Raw Materials Sources of Drug, Anti-infective Major Players in 2018
Table Downstream Buyers
Figure Global Drug, Anti-infective Production and Growth Rate Forecast (2019-2026)
Figure Global Drug, Anti-infective Revenue and Growth Rate Forecast (2019-2026)
Figure Global Drug, Anti-infective Price and Trend Forecast (2019-2026)
Table United States Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table China Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Japan Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table India Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Middle East and Africa Drug, Anti-infective Production, Consumption, Export and Import Forecast (2019-2026)
Table Global Drug, Anti-infective Market Production Forecast, by Type
Table Global Drug, Anti-infective Production Volume Market Share Forecast, by Type
Table Global Drug, Anti-infective Market Revenue Forecast, by Type
Table Global Drug, Anti-infective Revenue Market Share Forecast, by Type
Table Global Drug, Anti-infective Price Forecast, by Type
Table Global Drug, Anti-infective Market Production Forecast, by Application
Table Global Drug, Anti-infective Production Volume Market Share Forecast, by Application
Table Global Drug, Anti-infective Market Revenue Forecast, by Application
Table Global Drug, Anti-infective Revenue Market Share Forecast, by Application
Table Global Drug, Anti-infective Price Forecast, by Application
